The antifibrotic effect of PACAP suggested by our results is considerable, is likely mediated via the major (PAC1) receptor for PACAP, and appears to emerge only under metabolic stress conditions caused by CED. The gene discussed is ADCYAP1R1; the disease is cranioectodermal dysplasia.